Vaccine Strategies for the Prevention of Cytomegalovirus Disease

This publication has 100 references indexed in Scilit:

• The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope
  Journal of General Virology, 1990
• Reactivation and Recombination of Multiple Cytomegalovirus Strains from Individual Organ Donors
  The Journal of Infectious Diseases, 1989
• SYMPTOMATIC CYTOMEGALOVIRUS INFECTION IN SEROPOSITIVE KIDNEY RECIPIENTS: REINFECTION WITH DONOR VIRUS RATHER THAN REACTIVATION OF RECIPIENT VIRUS
  The Lancet, 1988
• Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant Recipients
  New England Journal of Medicine, 1987
• Young Children as a Probable Source of Maternal and Congenital Cytomegalovirus Infection
  New England Journal of Medicine, 1987
• Acquisition of Donor Strains of Cytomegalovirus by Renal-Transplant Recipients
  New England Journal of Medicine, 1986
• Congenital Cytomegalovirus Infection
  New England Journal of Medicine, 1982
• Prevention of transfusion-acquired cytomegalovirus infections in newborn infants
  The Journal of Pediatrics, 1981
• Immunization with Live Types 7 and 4 Adenovirus Vaccines. II. Antibody Response and Protective Effect against Acute Respiratory Disease Due to Adenovirus Type 7
  The Journal of Infectious Diseases, 1971
• Immunization with Live Types 7 and 4 Adenovirus Vaccines. I. Safety, Infectivity, Antigenicity, and Potency of Adenovirus Type 7 Vaccine in Humans
  The Journal of Infectious Diseases, 1971